Close Menu
Home » BostonGene Partners With NIH on Clonal Evolution Study

BostonGene Partners With NIH on Clonal Evolution Study

Jul 23, 2019
|
staff reporter

NEW YORK – BostonGene today announced a partnership with the National Institutes of Health to offer molecular profiling and therapy recommendations in a cancer study.

The software firm is launching a new study with collaborators at the National Cancer Institute and the National Institute of Allergy and Infectious Disease to analyze the clonal evolution of solid and liquid tumors in patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dec
17
Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Cancer

  1. UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment

  2. Tempus Acquires Commercial Lab, Precision Medicine Services Provider Akesogen

  3. ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

  4. Universal Genetic Testing in Breast Cancer May Result in More Harm Than Good, Experts Worry

    Premium

  5. New Data Emerges for Liquid Biopsy in Breast Cancer Residual Disease Detection

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.